Last update :
03/05/2024
References   References 3938  
Type : Manufacturer

Research teams :
Authors :
Title : Necitumumab (Portrazza®) – Résumé des caractéristiques du produits
Reference : Lilly S.A 2016

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionNecitumumab Anticancer drug
Factors which affect stability Solvent Glucose 5% Induces Degradation
Stability in solutions Not specified Sodium chloride 0,9% 16 mg/ml 2-8°C With or without light
24 Hour
Stability in solutions Not specified Sodium chloride 0,9% 16 mg/ml 9-25°C With or without light
4 Hour
Incompatible + Glucose 5%

  Mentions Légales